Maximus Inc. (MMS) CFO Acquires $50,100.00 in Stock
Maximus Inc. (NYSE:MMS) CFO Richard John Nadeau purchased 1,000 shares of the company’s stock in a transaction dated Friday, November 11th. The stock was purchased at an average cost of $50.10 per share, with a total value of $50,100.00. Following the purchase, the chief financial officer now owns 10,256 shares in the company, valued at $513,825.60. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink.
Maximus Inc. (NYSE:MMS) opened at 54.39 on Thursday. The stock’s 50 day moving average price is $53.73 and its 200 day moving average price is $56.15. The firm has a market capitalization of $3.58 billion, a price-to-earnings ratio of 20.22 and a beta of 1.15. Maximus Inc. has a 52-week low of $43.69 and a 52-week high of $61.68.
Maximus (NYSE:MMS) last announced its quarterly earnings data on Thursday, November 10th. The company reported $0.77 earnings per share for the quarter, beating analysts’ consensus estimates of $0.72 by $0.05. The firm had revenue of $623.10 million for the quarter, compared to analyst estimates of $610.65 million. Maximus had a net margin of 7.42% and a return on equity of 24.93%. The business’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same period in the previous year, the company earned $0.53 earnings per share. On average, equities analysts anticipate that Maximus Inc. will post $3.02 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 30th. Stockholders of record on Tuesday, November 15th will be issued a dividend of $0.045 per share. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.33%. The ex-dividend date is Thursday, November 10th. Maximus’s dividend payout ratio (DPR) is presently 6.67%.
MMS has been the subject of a number of research analyst reports. Zacks Investment Research cut shares of Maximus from a “hold” rating to a “sell” rating in a research report on Wednesday, October 5th. Sidoti cut shares of Maximus from a “buy” rating to a “neutral” rating in a research report on Tuesday. Maxim Group increased their price objective on shares of Maximus from $71.00 to $74.00 and gave the stock a “buy” rating in a research report on Thursday, August 4th. Raymond James Financial Inc. cut shares of Maximus from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 9th. Finally, Jefferies Group reaffirmed a “buy” rating and set a $65.00 price objective (down previously from $67.00) on shares of Maximus in a research report on Wednesday. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and five have assigned a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $62.75.
Large investors have recently made changes to their positions in the stock. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Maximus by 13.4% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,147 shares of the company’s stock valued at $121,000 after buying an additional 253 shares in the last quarter. Intl Fcstone Inc. bought a new stake in Maximus during the third quarter worth approximately $203,000. Navellier & Associates Inc bought a new stake in Maximus during the second quarter worth approximately $208,000. Parametrica Management Ltd bought a new stake in Maximus during the second quarter worth approximately $216,000. Finally, LS Investment Advisors LLC increased its stake in Maximus by 70.9% in the second quarter. LS Investment Advisors LLC now owns 3,928 shares of the company’s stock worth $217,000 after buying an additional 1,630 shares in the last quarter. 99.00% of the stock is currently owned by hedge funds and other institutional investors.
Maximus Company Profile
MAXIMUS, Inc provides business process services (BPS) to Government health and human services agencies. The Company is primarily focused on operating Government-sponsored programs, such as Medicaid, children’s health insurance program (CHIP), health insurance exchanges and other health care reform initiatives, Medicare, welfare-to-work, child support services and other Government programs.
Receive News & Stock Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related stocks with our FREE daily email newsletter.